Search results for "ffpe challenges"

Dr. Bruce Budowle discusses how probabilistic genotyping is helping forensic labs identify low-level, degraded DNA samples

Abcam scientist Dr. Yongwon Kwon discusses a new method that could help scientists simplify their gene-editing processes and extend the validation of cancer cells

R&D expert Dr. Francisco Ylera shares the secret to fast and flexible formatting of antibodies to accelerate your research

Sebastian Weber discusses the hot topic of digitized laboratories and why you should consider integrating software into your workflows

Meet the inflammation and immunity researcher studying the fundamental cellular mechanisms behind uncontrolled inflammatory responses to allergens

The automated volume reduction instrument from Menarini Silicon Biosystems was debuted at 25th annual meeting of the Association for Molecular Pathology

Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays

The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers

New NGS products for streamlined sample prep and ovarian cancer research

New name reflects the company’s evolution to provider of applied spectral knowledge

Fluorescent Annexin V conjugates that are optimized for bright and low background staining of extracellular vesicles for flow cytometry.

Leading scientist reveals more about her groundbreaking research exploring T cells that target SARS-CoV-2, which has inspired scientists from across the world to understand how T cells, rather than antibodies, drive immunity to the virus

Dr. Christian Frisch explains how to design a reliable assay and reveals how Bio-Rad and Sartorius teamed up to help scientists achieve peak immunoassay performance

Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes

Activities highlight comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine and further clinical research

Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease